atryn
laboratoire francais du fractionnement et des biotechnologies - antitrombīns, alfa - antitrombīna iii deficīts - antitrombotiskie līdzekļi - atryn ir norādīts profilakses vēnu trombembolija ķirurģijas pacientiem ar iedzimtu antithrombin deficīts. atryn parasti lieto kopā ar heparīnu vai mazmolekulāro heparīnu.
lodoz 5 mg/6,25 mg apvalkotās tabletes
merck romania srl, romania - bisoprololi fumaras, hydrochlorothiazidum - apvalkotā tablete - 5 mg/6,25 mg
lodoz 5 mg/6,25 mg apvalkotās tabletes
merck romania srl, romania - bisoprololi fumaras, hydrochlorothiazidum - apvalkotā tablete - 5 mg/6,25 mg
quercetina proactive (2022.) kapsula
kapsula
immunace® extra protection™ (2016.) tablete
vitabiotics ltd. - tablete
joint protection (paziņots 2009.) kapsula
uab vitaforce - kapsula
joint protection kapsula
vitaforce, uab - kapsula
urbase® iii - protection aufbau - basenpulver, 200 g (2023. ) pulveris
pulveris
cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorāģija - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.